Showing results (61-70 of 65) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Gynecologic Oncology|February 7, 2024
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trialBhavana Pothuri, Sileny Han, Dana M Chase, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2025
Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized studyIgnace Vergote, Larry J Copeland, Toon Van Gorp, et al.Gynecologic Oncology|July 1, 2025
Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancerLeslie Randall, Yang Xiang, Takashi Matsumoto, et al.International Journal of Cancer|October 10, 2022
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriersKeren Bahar-Shany, Georgina D Barnabas, Lisa Deutsch, et al.Human Mutation|February 16, 2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutationsTimothy R Rebbeck, Tara M Friebel, Eitan Friedman, et al.Pageof 7